News
Efimosfermin is a phase III-ready, investigational specialty medicine with the potential to be best-in-class for treating and preventing the progression of steatotic liver disease (SLD).
Affecting up to 5% of the global population, SLD represents an area of significant unmet medical need with limited treatment options Phase II data show potential of efimosfermin to reverse liver ...
Affecting up to 5% of the global population, SLD represents an area of significant unmet medical need with limited treatment options Phase II data show potential of efimosfermin to reverse liver ...
SINGAPORE: China’s decision not to send its defence minister Dong Jun to this year’s Shangri-La security dialogue (SLD) in Singapore reflects a deliberate decision on Beijing’s part to ...
The cannabidiol (CBD) world can feel huge and complicated, but products like CBD gummies make it more approachable for some folks. CBD gummies are easy to dose, portable, and discreet. They also ...
As the absence of China's defence minister from China continues to be felt on the second day of the Shangri-La Dialogue (SLD), China has responded: “It’s a completely normal work arrangement.” ...
China has responded to comments made by U.S. Defence Secretary Pete Hegseth at the 2025 Shangri-La Dialogue, saying that the U.S. is promoting a Cold War mentality and warned them against "playing ...
How in-design analysis helps engineers catch and fix SI/PI challenges early, saving time, reducing risks, and ensuring first-pass success.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results